MyWayUp: A Digital Intervention for Alcohol Use Disorder in Patients With Alcohol-Related Liver Disease-Results From an RCT


Por: Oliveras, C, Balcells-Oliveró, M, Bataller, R, Bruguera, P, Cabrera, N, Calomarde-Gomez, C, Caballeria, E, Freixa, N, Garcia-Pañella, O, Gratacós-Ginès, J, Guzman, P, Hernández-Rubio, A, Lligoña, A, Ortega, L, Pérez-Guasch, M, Pons-Cabrera, MT, Pose, E, Zuluaga, P and López-Pelayo, H

Publicada: 5 ene 2026
Resumen:
Background: Alcohol-related liver disease (ArLD) is a public health concern that requires multidisciplinary interventions. Digital health tools may improve retention in alcohol use disorder (AUD) treatment and enhance health outcomes. This study explores a blended intervention (brief intervention plus a serious game (SG) based on motivational interviewing and cognitive-behavioural therapy) on AUD in patients with ArLD. Methods: Randomised, single-blinded controlled trial on patients with recent-onset ArLD and AUD. Brief intervention plus the SG was compared to standard addiction therapy. Primary outcomes were AUD treatment retention and adherence at 6 months. Secondary outcomes included liver disease progression, alcohol use patterns, quality of life, functionality, motivational changes and usability. Results: Seventy-nine patients (mean age 56, MELD-Na 14) were included. Participants in the intervention arm were three times more likely to remain in treatment at month six than those in the control arm (adjusted odds ratio (aOR) 3.24; 82.9% vs. 47.4% of engagement respectively) and attended 50% more appointments. Effect sizes (Cohen's D) were moderate for adherence at months three and six (0.51-0.64). At 6 months, Model for End-Stage Liver Disease Sodium (MELD-Na) scores were lower in the experimental group (12 vs. 16, p < 0.001). Among baseline drinkers, alcohol consumption decreased more in the intervention group at month one (11 vs. 6 Standard Drink Units (SDU)/day, p = 0.031). Conclusion: The blended intervention increases engagement with AUD treatment, reduces the amount of consumed alcohol and improves MELD-Na scores. These results support the use of digital tailored interventions for AUD in these patients.

Filiaciones:
Oliveras, C:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Balcells-Oliveró, M:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Bataller, R:
 Univ Barcelona, Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer, Grp Enfermedades Hepat Cron Mecanismos Mol & Conse, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain

Bruguera, P:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Cabrera, N:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Caballeria, E:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Freixa, N:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Guzman, P:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Lligoña, A:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Ortega, L:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Pose, E:
 Univ Barcelona, Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer, Grp Enfermedades Hepat Cron Mecanismos Mol & Conse, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain

Zuluaga, P:
 Hosp Univ Germans Trias I Pujol, Dept Internal Med, Addict Unit, Internal Med, Badalona, Spain

 Inst Recerca Germans Trias i Pujol IGTP, Badalona, Spain

 Univ Autonoma Barcelona, Dept Med, Barcelona, Spain

López-Pelayo, H:
 Inst Invest Biomed August Pi I Sunyer, Hlth & Addict Res Grp Grup Recerca Emergent, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Psychiat & Psychol, Addict Unit, Barcelona, Catalonia, Spain

 Univ Barcelona, Barcelona, Spain

Hosp Univ Germans Trias I Pujol, Rheumatol Dept, Badalona, Spain
Cookie Box SL, Barcelona, Spain
Univ Barcelona, New Interact Technol Sch ENTI, Barcelona, Spain
ISSN: 14783231





Liver International
Editorial
Blackwell Publishing Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 46 Número: 2
Páginas:
WOS Id: 001654104500001
ID de PubMed: 41489222
imagen Bronze

MÉTRICAS